Validation of dynamic random dot stereotests in pediatric vision screening.


Journal

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
ISSN: 1435-702X
Titre abrégé: Graefes Arch Clin Exp Ophthalmol
Pays: Germany
ID NLM: 8205248

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 04 05 2018
accepted: 18 09 2018
revised: 11 09 2018
pubmed: 5 10 2018
medline: 20 2 2019
entrez: 5 10 2018
Statut: ppublish

Résumé

Stereo vision tests are widely used in the clinical practice for screening amblyopia and amblyogenic conditions. According to literature, none of these tests seems to be suitable to be used alone as a simple and reliable tool. There has been a growing interest in developing new types of stereo vision tests, with sufficient sensitivity to detect amblyopia. This new generation of assessment tools should be computer based, and their reliability must be statistically warranted. The present study reports the clinical evaluation of a screening system based on random dot stereograms using a tablet as display. Specifically, a dynamic random dot stereotest with binocularly detectable Snellen-E optotype (DRDSE) was used and compared with the Lang II stereotest. A total of 141 children (aged 4-14, mean age 8.9) were examined in a field study at the Department of Ophthalmology, Pécs, Hungary. Inclusion criteria consisted of diagnoses of amblyopia, anisometropia, convergent strabismus, and hyperopia. Children with no ophthalmic pathologies were also enrolled as controls. All subjects went through a regular pediatric ophthalmological examination before proceeding to the DRDSE and Lang II tests. DRDSE and Lang II tests were compared in terms of sensitivity and specificity for different conditions. DRDSE had a 100% sensitivity both for amblyopia (n = 11) and convergent strabismus (n = 21), as well as a 75% sensitivity for hyperopia (n = 36). However, the performance of DRDSE was not statistically significant when screening for anisometropia. On the other hand, Lang II proved to have 81.8% sensitivity for amblyopia, 80.9% for strabismus, and only 52.8% for hyperopia. The specificity of DRDSE was 61.2% for amblyopia, 67.3% for strabismus, and 68.6% for hyperopia, respectively. Conversely, Lang II showed about 10% better specificity, 73.8% for amblyopia, 79.2% for strabismus, and 77.9% for hyperopia. The DRDSE test has a better sensitivity for the detection of conditions such as amblyopia or convergent strabismus compared with Lang II, although with slightly lower specificity. If the specificity could be further improved by optimization of the stimulus parameters, while keeping the sensitivity high, DRDSE would be a promising stereo vision test for screening of amblyopia.

Identifiants

pubmed: 30284041
doi: 10.1007/s00417-018-4147-x
pii: 10.1007/s00417-018-4147-x
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

413-423

Subventions

Organisme : PTE AOK
ID : PTE AOK-KA-2017-06
Organisme : Comprehensive Development for Implementing Smart Specialization Strategies at the University of Pécs, and by the European Union, co-financed by the European Social Fund
ID : EFOP-3.6.1.-16-2016-00004
Organisme : Hungarian Brain Research Program
ID : KTIA _NAP_13-1-2013-0001
Organisme : OTKA
ID : OTKA K108747

Références

Am J Ophthalmol. 1974 Oct;78(4):707-13
pubmed: 4411731
Br J Ophthalmol. 2002 Oct;86(10):1148-51
pubmed: 12234897
Am J Epidemiol. 2004 May 1;159(9):882-90
pubmed: 15105181
Optom Vis Sci. 2008 Nov;85(11):1074-81
pubmed: 18981922
Jpn J Ophthalmol. 2013 May;57(3):316-9
pubmed: 23381346
J Pediatr Ophthalmol Strabismus. 1997 Jul-Aug;34(4):217-22; quiz 247-8
pubmed: 9253735
Curr Opin Ophthalmol. 2013 Sep;24(5):415-20
pubmed: 23872813
Ophthalmic Physiol Opt. 1991 Jan;11(1):3-9
pubmed: 2034452
Pediatr Clin North Am. 1987 Dec;34(6):1389-401
pubmed: 3317236
J Pediatr Ophthalmol Strabismus. 1991 May-Jun;28(3):131-3
pubmed: 1890568
Indian J Ophthalmol. 2008 Jan-Feb;56(1):45-50
pubmed: 18158403
Acta Ophthalmol Scand. 2002 Apr;80(2):163-6
pubmed: 11952482
J Pediatr Ophthalmol Strabismus. 1983 Mar-Apr;20(2):72-4
pubmed: 6864421
J Vis. 2003;3(5):380-405
pubmed: 12875634
Klin Monbl Augenheilkd. 1998 Sep;213(3):166-73
pubmed: 9793915
Sci Rep. 2017 Oct 17;7(1):13410
pubmed: 29042639
J Clin Diagn Res. 2016 May;10(5):NC14-7
pubmed: 27437256
PLoS One. 2018 Jan 5;13(1):e0188895
pubmed: 29304135
Br J Ophthalmol. 1996 Dec;80(12):1077-82
pubmed: 9059274
BMC Ophthalmol. 2014 Dec 23;14:163
pubmed: 25539893
J AAPOS. 2001 Oct;5(5):316-22
pubmed: 11641643
J Vis. 2016 Nov 1;16(14):13
pubmed: 27846341
Comput Biol Med. 1981;11(1):33-46
pubmed: 7014078
Aust N Z J Ophthalmol. 1990 Aug;18(3):319-24
pubmed: 2261180
Ophthalmic Physiol Opt. 2016 Nov;36(6):611-614
pubmed: 27790768
BMJ. 1994 Jun 11;308(6943):1552
pubmed: 8019315
Ophthalmology. 1980 Dec;87(12):1265-72
pubmed: 7243215
Br J Ophthalmol. 2013 Mar;97(3):308-13
pubmed: 23292927
J Med Screen. 2015 Jun;22(2):55-64
pubmed: 25742803
Proc Natl Acad Sci U S A. 1980 Apr;77(4):2348-51
pubmed: 6769126
Am J Ophthalmol. 2005 Dec;140(6):1130-2
pubmed: 16376664
Ophthalmic Physiol Opt. 1993 Oct;13(4):350-6
pubmed: 8278186
Vision Res. 1986;26(4):621-30
pubmed: 3739237
J Neurophysiol. 1963 Nov;26:978-93
pubmed: 14084170
Public Health Rep. 2013 May-Jun;128(3):189-97
pubmed: 23633734
J AAPOS. 2003 Oct;7(5):333-8
pubmed: 14566315
J Am Optom Assoc. 1994 Oct;65(10):725-31
pubmed: 7995896
Ophthalmology. 2013 Mar;120(3):495-503
pubmed: 23174398
Ophthalmic Epidemiol. 2000 Dec;7(4):249-58
pubmed: 11262672
Ophthalmology. 2013 Oct;120(10):2117-24
pubmed: 23697956
Eye (Lond). 2011 Apr;25(4):403-13
pubmed: 21274010
J Pediatr Ophthalmol Strabismus. 2001 Sep-Oct;38(5):284-94
pubmed: 11587177
Clin Chem. 1993 Apr;39(4):561-77
pubmed: 8472349
Lancet. 2006 Apr 22;367(9519):1343-51
pubmed: 16631913
Am J Ophthalmol. 1975 Nov;80(5):893-900
pubmed: 1190281
Neurosci Lett. 2008 May 23;437(1):5-9
pubmed: 18423988
Invest Ophthalmol Vis Sci. 2001 Mar;42(3):875-8
pubmed: 11222553
Prog Retin Eye Res. 2013 Mar;33:67-84
pubmed: 23201436
Optom Vis Sci. 2015 Jan;92(1):6-16
pubmed: 25562476
Surv Ophthalmol. 1983 Nov-Dec;28(3):145-63
pubmed: 6670062
Ophthalmology. 1998 Jan;105(1):154-9
pubmed: 9442792
Vision Res. 2000;40(13):1775-83
pubmed: 10814762
J Pediatr Ophthalmol Strabismus. 1986 Nov-Dec;23(6):298-302
pubmed: 3454373
Acta Paediatr. 2000 Jul;89(7):824-9
pubmed: 10943966
Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1139-48
pubmed: 17325157
Optom Vis Sci. 2012 Nov;89(11):e44-9
pubmed: 23069721
Clin Exp Optom. 2005 Nov;88(6):365-75
pubmed: 16329744
J AAPOS. 1999 Feb;3(1):15-7
pubmed: 10071896
Ophthalmic Physiol Opt. 1990 Jan;10(1):3-7
pubmed: 2184389
Am Orthopt J. 2012;62:87-9
pubmed: 22848116
Arch Ophthalmol. 1983 Jun;101(6):930-2
pubmed: 6860208
Clin Exp Ophthalmol. 2006 Nov;34(8):743-50
pubmed: 17073896
Acta Ophthalmol (Copenh). 1984 Feb;62(1):156-62
pubmed: 6720272
J Vis. 2009 Apr 06;9(4):8.1-10
pubmed: 19757917

Auteurs

Anna Budai (A)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary.

András Czigler (A)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary.

Eszter Mikó-Baráth (E)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary.

Vanda A Nemes (VA)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary.

Gábor Horváth (G)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary.

Ágota Pusztai (Á)

Department of Ophthalmology, University of Pécs, Medical School, Rákóczi út 2., Pécs, 7623, Hungary.

David P Piñero (DP)

Department of Optics, Pharmacology and Anatomy, University of Alicante, Carr. San Vicente del Raspeig, 03690, San Vicente del Raspeig, Alicante, Spain.

Gábor Jandó (G)

Institute of Physiology, University of Pécs, Medical School, Szigeti út 12., Pécs, 7624, Hungary. gabor.jando@aok.pte.hu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH